Psychopharmacology and Psychiatry Updates
Podcast tekijän mukaan Psychopharmacology Institute
Kategoriat:
213 Jaksot
-
Acute Agitation and Dexmedetomidine: A Novel Treatment Approach
Julkaistiin: 30.8.2023 -
The Prevalence and Risks of RBD
Julkaistiin: 25.8.2023 -
ADHD Medication and Their Role in Anxiety and Depression
Julkaistiin: 20.8.2023 -
In the Realm of Sleep: RBD Diagnosis Explained
Julkaistiin: 15.8.2023 -
NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?
Julkaistiin: 10.8.2023 -
Child Psychiatry: NAC and SAMe
Julkaistiin: 5.8.2023 -
Youth Psychotropic Prescription Trends: Pandemic Influence
Julkaistiin: 31.7.2023 -
Nature's Remedies in Youth: St. John's Wort and Valerian
Julkaistiin: 26.7.2023 -
Exploring Serotonergic Antidepressants for PMDD
Julkaistiin: 21.7.2023 -
Exploring Omega-3's Role in Child Psychiatry
Julkaistiin: 16.7.2023 -
ADHD Meds for Preschoolers: Lisdexamfetamine
Julkaistiin: 11.7.2023 -
Using Ginkgo Biloba in Children
Julkaistiin: 6.7.2023 -
Examining COVID's Lasting Effects in Psychiatry
Julkaistiin: 1.7.2023 -
Beyond SSRIs: Antipsychotic Augmentation in OCD
Julkaistiin: 26.6.2023 -
Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs
Julkaistiin: 21.6.2023 -
Exploring Outcomes and Strategies in OCD Treatment After the First Trial
Julkaistiin: 16.6.2023 -
Diving Into the APA Annual Meeting: Highlights and Insights!
Julkaistiin: 11.6.2023 -
Exploring the Intriguing World of Microdosing Psilocybin
Julkaistiin: 6.6.2023 -
SSRIs for OCD: A Closer Look at First-Line Treatment
Julkaistiin: 1.6.2023 -
Exploring Nonstimulant Treatments for ADHD
Julkaistiin: 27.5.2023
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.